TXT vs USBC
Textron Inc (TXT) versus US BioTec Inc (USBC) — a side-by-side from cached financials, not a winner call.
Textron Inc (TXT) is a aerospace & defense company listed on US.
US BioTec Inc (USBC) is a agricultural inputs company listed on US.
Latest reported TXT revenue for 2024-12-28 was $13.70B. Net income was $824.0M. Revenue was up 0.1% from 2023-12-30 to 2024-12-28. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
Latest reported USBC revenue for 2023-09-30 was $0. Net income was -$15.3M. Revenue was down 100.0% from 2022-09-30 to 2023-09-30. USBC currently screens at market cap $0.
TXT currently screens at market cap $14.85B and trailing P/E 18.5. USBC currently screens at market cap $0.
Not investment advice. Open the TXT and USBC stock pages for the full models.
Not investment advice.